Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Is the Dronabinol even being looked at?

<< Previous

Bullboard Posts

Next >>

Comment by JohnnyRingo20on Jun 03, 2022 9:51am

82 Views

Post# 34729328

RE:Is the Dronabinol even being looked at?

NSX001 wrote: I've not seen the Dronabinol submission level move for quite some time now. It's been stuck at level "6" and not moved. What seems to be the problem? Is Health Canada even looking at it? Does Guy and his team even bother to inquire as to why the delay?

The delay due to Covid bullsh*t doesn't cut it anymore, there's something else going on here, were now into 7 months of delays. Even Health Canada is not that slow.

NSX001

stay close to the phone. Any day now. Judging by our sp the market doesn't have faith in TBP.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"